CVS Health does a 180. On May 28, CVS Caremark, the pharmacy benefits manager (PBM) under CVS Health's umbrella, announced it ...

Eli Lilly (LLY) just did something worth paying attention to. With CVS Caremark announcing coverage of both Zepbound and ...

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ...

Eli Lilly stock gains 14% in a month as strong Q1 results, obesity drug coverage expansion and promising retatrutide data ...

Eli Lilly and Company (NYSE:LLY) is one of the 10 Best American Stocks to Buy and Hold for the Next Decade. On May 31, 2026, Eli Lilly and Company (NYSE:LLY) announced results from the Phase 3 ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

Mark Cuban’s healthcare strategy targets high drug costs, insurance complexity and transparency, offering a simpler model ...

CVS Caremark has moved to cover Eli Lilly's full obesity drug portfolio, including the newly approved oral therapy Foundayo.

The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not ...

A new law passed overwhelmingly by the Tennessee legislature may force the state's second-largest drug store chain to vamoose.

While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust ...

Explore US health insurance stocks, key managed care risks, Medicare Advantage pressure, and major healthcare names shaping ...